Charles Oh

Bioequivalence and Safety Comparison of Once-Weekly Donepezil Transdermal System With Oral Donepezil: Results of a Phase 1 Pharmacokinetic Study in Healthy Volunteers

Abstract: Oral donepezil is widely prescribed for dementia of the Alzheimer’s type. Donepezil transdermal system (TDS; Adlarity®) was also recently approved. Here, we report bioequivalenc...

Charles Oh ;

Mary Wiggin ;

01/19/2023

Evaluation of Skin Adhesion and Local Skin Tolerability of Once-Weekly Donepezil Transdermal System: Results of a Phase 1 Trial in Healthy Volunteers

Abstract: Donepezil transdermal system (TDS; Adlarity®) is approved for dementia of the Alzheimer’s type. Reported here are skin-adhesion and skin-tolerability evaluations of donepezil TD...

Charles Oh ;

Mary Wiggin ;

01/19/2023